| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Korean Journal of Otorhinolaryngology-Head and Neck Surgery > Volume 36(3); 1993 > Article
Korean Journal of Otorhinolaryngology-Head and Neck Surgery 1993;36(3): 413-420.
A study for the incidence of neck metastasis in head and neck cancer.
Tae Hyeon Song, Seung Ju Lee, Yoon Young Chung, Cheon Hwan Oh
두경부 악성종양의 경부전이 빈도에 관한 고찰
송태현 · 이승주 · 정윤영 · 오천환
순천향대학교 의과대학 천안병원 이비인후과학교실
ABSTRACT

Neck metastasis is one of the major problems in head and neck cancers and it affects the method of treatment and the prognosis. The authors studied the incidence of neck metastasis in 90 patients who were confirmed with head and neck cancers by histopathology from January 1987 to March 1992 at the Department of Otolaryngology, Chunan Hospital, College of Medicine, Soonchunhyang University. The results were as follows : 1) In age distribution, the sixth decade had a predilection(36.7%) for head and neck cancers and the frequency of neck metastasis was common in the fifth and sixth decades(p>0.05). The ratio of male to female was 3.5 : 1 in head and neck cancer and about 2.1 : 1 in neck metastasis. 2) The most common duration of symptom was 6 months(74.5%) and the frequency of neck metastasis was high by duration. 3) In histopathology, the squamous cell carcinoma was the most common with 73 cases(81.1%) of which 28 cases(38.4%) had neck metastasis. 4) The primary sites of the head and neck cancer except malignant lymphoma were larynx(31.0%) and pharynx(29.8%) in order. Neck metastasis was in 33 case(39.3%), which were primarily originated from the oral cavity, pharynx and larynx. 5) The higher T classification was, the more neck metastasis occurred. Among 69 cases except the malignant tumors of ear, nose and paranasal sinuses and the malignant lymphoma, 33 cases(47.8%) showed neck metastasis. 6) Neck metastasis was the most common in pharynx with 13 cases. N classification was common in N1, 15 cases(45.5%)(N1, 90.0% in oral cavity, N2b, 38.5% in pharynx, N1, 40.0% in larynx).

TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Share:      
METRICS
1,258
View
1
Download
Related articles
Drug Repositioning for Treatment of Head and Neck Cancers  2023 August;66(8)
The Role of MicroRNA in Head and Neck Cancer  2022 February;65(2)
Targeting Fatty Acid Metabolism in Head and Neck Cancer  2021 June;64(6)
Epithelial-Mesenchymal Transition in Head and Neck Cancer  2020 September;63(9)
Antibody-Drug Conjugates in Head and Neck Cancer  2017 July;60(7)
Editorial Office
Korean Society of Otorhinolaryngology-Head and Neck Surgery
103-307 67 Seobinggo-ro, Yongsan-gu, Seoul 04385, Korea
TEL: +82-2-3487-6602    FAX: +82-2-3487-6603   E-mail: kjorl@korl.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Society of Otorhinolaryngology-Head and Neck Surgery.                 Developed in M2PI
Close layer
prev next